US Broker Ratings

Chevron Corporation (CVX) Stock Analysis: Is a 9.81% Upside Within Reach?

Chevron Corporation (NYSE: CVX), a titan in the energy sector, remains a focal point for investors seeking stability and growth in the oil & gas integrated industry. With a market..

Benitec Biopharma Inc. (BNTC) Stock Analysis: A Potential 77% Upside Awaits Investors

Benitec Biopharma Inc. (BNTC), a clinical-stage biotechnology company, has been capturing the attention of investors with its innovative approach to genetic medicine. Headquartered in Hayward, California, Benitec is at the..

TruBridge, Inc. (TBRG) Stock Analysis: Evaluating a 21.80% Potential Upside in Healthcare Tech

TruBridge, Inc. (NASDAQ: TBRG), a key player in the healthcare sector, has been making waves with its specialized health information services. Focusing on community hospitals and clinics, TruBridge provides innovative..

Erasca, Inc. (ERAS) Stock Analysis: Exploring a 106.85% Upside Potential in Precision Oncology

Erasca, Inc. (ERAS), a clinical-stage precision oncology company, is capturing the attention of investors with its focus on developing therapies for RAS/MAPK pathway-driven cancers. Despite its current stock price of..

Wave Life Sciences Ltd. (WVE) Stock Analysis: Unpacking the 177.70% Potential Upside in Biotech Innovation

Wave Life Sciences Ltd. (WVE), a Singapore-based biotechnology company, is capturing the attention of investors with its groundbreaking RNA medicines and a staggering potential upside of 177.70%. With a market..

NeoGenomics, Inc. (NEO) Stock Analysis: A Look at Its 28.7% Potential Upside and Analyst Sentiment

For investors keen on the healthcare sector, NeoGenomics, Inc. (NASDAQ: NEO) presents a compelling opportunity with its focus on cancer diagnostics and research. Headquartered in Fort Myers, Florida, NeoGenomics operates..

Establishment Labs Holdings Inc (ESTA) Stock Analysis: Exploring a 34% Potential Upside in the Healthcare Sector

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a company at the forefront of the medical devices industry, is capturing attention with its significant potential upside of 34.02%. Headquartered in Alajuela, Costa..

agilon health, inc. (AGL) Stock Analysis: Eyeing a 33.75% Upside in a Challenging Market Landscape

agilon health, inc. (NYSE: AGL) is a player in the healthcare sector, specifically within the medical care facilities industry. Based in Westerville, Ohio, the company focuses on providing healthcare services..

U.S. Physical Therapy, Inc. (USPH): Investor Outlook on Strong Revenue Growth and Upside Potential

U.S. Physical Therapy, Inc. (NYSE: USPH), a prominent player in the healthcare sector, is making waves with its impressive revenue growth and a substantial potential upside of 28.14%. Headquartered in..

Evolent Health, Inc. (EVH) Stock Analysis: A Potential 76% Upside with Strong Buy Ratings

Evolent Health, Inc. (NYSE: EVH), a key player in the healthcare sector, is garnering significant attention from investors with its focus on specialty care management services in areas such as..

Harrow, Inc. (HROW) Stock Analysis: A 37% Potential Upside Captivates Investors

In the bustling realm of the healthcare sector, Harrow, Inc. (NASDAQ: HROW) stands out as a burgeoning player in the specialty and generic drug manufacturing industry. With its focus on..

Pacira BioSciences, Inc. (PCRX) Investor Outlook: A 14.44% Upside Amidst Healthcare Innovations

Pacira BioSciences, Inc. (NASDAQ: PCRX), a prominent player in the healthcare sector, stands at the forefront of non-opioid pain management solutions. With a market capitalization of $1.14 billion, this Tampa-based..

ARS Pharmaceuticals, Inc. (SPRY) Stock Analysis: A Biotech Prospect with a 222% Upside Potential

Investors looking for promising opportunities in the biotechnology sector may find ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) an intriguing prospect. With a market capitalization of $968.5 million, this San Diego-based company..

Immunocore Holdings plc (IMCR) Growth Potential: Analyst Ratings Suggest an 81% Upside

Immunocore Holdings plc (NASDAQ: IMCR), a UK-based biotechnology company, has captured investor attention with its promising pipeline of immunotherapies targeting cancer, infectious, and autoimmune diseases. As the healthcare sector continues..

Dyne Therapeutics, Inc. (DYN) Stock Analysis: 178.4% Potential Upside Sparks Investor Interest

Dyne Therapeutics, Inc. (NASDAQ: DYN) is making waves in the biotechnology sector with its ambitious approach to tackling neuromuscular diseases. This clinical-stage company, headquartered in Waltham, Massachusetts, is harnessing its..

Amphastar Pharmaceuticals, Inc. (AMPH) Stock Analysis: Exploring a 21.35% Potential Upside

Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH), a notable player in the healthcare sector, particularly within the specialty and generic drug manufacturing industry, offers a compelling investment opportunity with a potential upside..

Astrana Health Inc. (ASTH) Stock Analysis: Exploring a 55% Upside Potential

Astrana Health Inc. (ASTH), a prominent player in the healthcare sector, is capturing investor attention with a robust potential upside of approximately 55.28%. Specializing in medical care facilities, Astrana Health..

ANI Pharmaceuticals, Inc. (ANIP) Stock Analysis: Strong Buy Ratings and 14.22% Upside Potential

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) has emerged as a notable player in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. With a market cap of $2.05..

MiMedx Group, Inc (MDXG) Stock Analysis: Exploring a 76% Potential Upside in the Biotechnology Sector

Investors with an eye on the healthcare sector might want to pay close attention to MiMedx Group, Inc. (NASDAQ: MDXG), a company entrenched in the biotechnology industry. With its focus..

Healthcare Services Group, Inc. (HCSG) Stock Analysis: Unpacking a 9.16% Potential Upside

Healthcare Services Group, Inc. (NASDAQ: HCSG), a notable player in the medical care facilities industry, offers a compelling investment narrative with a promising 9.16% potential upside. With a market capitalization..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds